Latest News and Press Releases

NEWARK, Del, July 21, 2023 (GLOBE NEWSWIRE) -- The global Antiviral Drugs Market has experienced a remarkable surge in recent years, driven by mounting global health concerns and the urgent need for...

New York, April 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the antiviral drugs market size is projected to surpass around USD 71.1 billion by 2032 from USD 49.8 billion in 2022, and it is...

New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Reverse Transcriptase Inhibitors to account for Over 50% of the Antiviral Drugs Sales in the Forthcoming Years, Forecasts Persistence Market Research ...

London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Antiviral Drugs Market, 2022 – 2035” report to its list of offerings. The recent COVID-19 pandemic has...

Pune, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The global antiviral drugs market is expected to clock US$ 66.79 billion by 2030 owing to presence of a well-established supply chain, rising interest in...

SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights’ analysis, the global antiviral drugs market is estimated to be valued at US$ 56,480.7 million in 2021 and is...

Visiongain has published a new report on Multiple Sclerosis Drugs Market Report 2021-2031:Forecasts By Drug Class (Corticosteroids, Interferon Beta, Sphingosine 1 Phosphate Receptor Modulators, Mixed...

Pune, India, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The global antiviral drugs market is set to gain impetus from the improvements in research collaborations of industry giants to develop...

Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...

Visiongain has published a new report on “CNS Therapeutics Market Forecast, 2021-2031”. Forecasts by Disease (Neurovascular Disease, Trauma, Mental Health, Degenerative, Others), End Use (Hospitals,...